Skip to main content
. 2018 Jan 26;2018(1):CD012551. doi: 10.1002/14651858.CD012551.pub2
Methods Study design: parallel group randomised trial.
Study dates: not available.
Setting: not available.
Country: South Korea.
Participants Inclusion criteria: not available.
Exclusion criteria: not available.
Sample size: 30.
Age: not available.
Sex: men.
Interventions Group 1 (n = not available): radiofrequency.
Group 2 (n = not available): 'placebo therapy.'
Cointerventions: not available.
Outcomes Prostatitis symptoms
How measured: NIH‐CPSI and Pelvic Pain Symptoms Survey.
Time points measured: baseline, and 1 month after treatment.
Time points reported: only P value of 1 month after treatment.
Funding sources None.
Declarations of interest Not available.
Notes We extracted this information from an abstract presentation. We contacted the authors: Dr Oh (mamah@hanmail.net) and Dr Bae (urobae@genetherapy.or.kr) and they mentioned that there was no publication available.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Abstract only.
Allocation concealment (selection bias) Unclear risk Abstract only.
Blinding of participants and personnel (performance bias) Subjective outcomes Unclear risk Abstract only.
Blinding of outcome assessment (detection bias) All outcomes Unclear risk Abstract only.
Incomplete outcome data (attrition bias) All outcomes Unclear risk Abstract only.
Selective reporting (reporting bias) Unclear risk Abstract only.
Other bias Unclear risk Abstract only.